These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26096936)
1. Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients. Liu J; You P; Chen G; Fu X; Zeng X; Wang C; Huang Y; An L; Wan X; Navone N; Wu CL; McKeehan WL; Zhang Z; Zhong W; Wang F Oncogene; 2016 Apr; 35(14):1750-9. PubMed ID: 26096936 [TBL] [Abstract][Full Text] [Related]
2. Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis. Zhang Y; Zhang J; Lin Y; Lan Y; Lin C; Xuan JW; Shen MM; McKeehan WL; Greenberg NM; Wang F Development; 2008 Feb; 135(4):775-84. PubMed ID: 18184727 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression. Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment. Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Lin ZY; Chen G; Zhang YQ; He HC; Liang YX; Ye JH; Liang YK; Mo RJ; Lu JM; Zhuo YJ; Zheng Y; Jiang FN; Han ZD; Wu SL; Zhong WD; Wu CL Mol Cancer; 2017 Feb; 16(1):48. PubMed ID: 28241827 [TBL] [Abstract][Full Text] [Related]
7. The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma. Ho TH; Liu XD; Huang Y; Warneke CL; Johnson MM; Hoang A; Tamboli P; Wang F; Jonasch E BMC Cancer; 2015 Apr; 15():304. PubMed ID: 25900027 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor. Zhang Y; McKeehan K; Lin Y; Zhang J; Wang F Mol Endocrinol; 2008 Jan; 22(1):167-75. PubMed ID: 17901128 [TBL] [Abstract][Full Text] [Related]
9. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Zhao Y; Adjei AA Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391 [TBL] [Abstract][Full Text] [Related]
10. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712 [TBL] [Abstract][Full Text] [Related]
11. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway. Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159 [TBL] [Abstract][Full Text] [Related]
12. Decreased Expression of MYPT1 Contributes to Tumor Angiogenesis and Poor Patient Prognosis in Human Prostate Cancer. Liang Y; Zhuo Y; Lin Z; Jiang F; Dai Q; Lu J; Dong W; Zhu X; Han Z; Zhong W Curr Mol Med; 2018; 18(2):100-108. PubMed ID: 29974831 [TBL] [Abstract][Full Text] [Related]
13. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955 [TBL] [Abstract][Full Text] [Related]
14. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors. Indraccolo S Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974 [TBL] [Abstract][Full Text] [Related]
15. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Lax I; Wong A; Lamothe B; Lee A; Frost A; Hawes J; Schlessinger J Mol Cell; 2002 Oct; 10(4):709-19. PubMed ID: 12419216 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202 [TBL] [Abstract][Full Text] [Related]
17. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Karashima T; Sweeney P; Slaton JW; Kim SJ; Kedar D; Izawa JI; Fan Z; Pettaway C; Hicklin DJ; Shuin T; Dinney CP Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546 [TBL] [Abstract][Full Text] [Related]
19. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Gotoh N; Ito M; Yamamoto S; Yoshino I; Song N; Wang Y; Lax I; Schlessinger J; Shibuya M; Lang RA Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17144-9. PubMed ID: 15569927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]